Correlation Between Edgewise Therapeutics and Relmada Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Relmada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Relmada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Relmada Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Relmada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Relmada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Relmada Therapeutics.

Diversification Opportunities for Edgewise Therapeutics and Relmada Therapeutics

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Edgewise and Relmada is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Relmada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relmada Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Relmada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relmada Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Relmada Therapeutics go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and Relmada Therapeutics

Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.79 times more return on investment than Relmada Therapeutics. However, Edgewise Therapeutics is 1.27 times less risky than Relmada Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Relmada Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  853.00  in Edgewise Therapeutics on September 14, 2024 and sell it today you would earn a total of  1,950  from holding Edgewise Therapeutics or generate 228.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Edgewise Therapeutics  vs.  Relmada Therapeutics

 Performance 
       Timeline  
Edgewise Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Relmada Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Relmada Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Edgewise Therapeutics and Relmada Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edgewise Therapeutics and Relmada Therapeutics

The main advantage of trading using opposite Edgewise Therapeutics and Relmada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Relmada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relmada Therapeutics will offset losses from the drop in Relmada Therapeutics' long position.
The idea behind Edgewise Therapeutics and Relmada Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments